A new Ebola vaccine, designed in collaboration with scientists from the University of Texas Medical Branch at Galveston, is entering early clinical trials that will test its safety and ability to produce an immune response. Read more: chron.com
Our Blog
Ambry Genetics Launches Cost-free, Cloud-based Software to Help Clinicians and Researchers Maximize Genetic and Family History Data
Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, today launched Progeny Cloud, the most complete, affordable, and hassle-free way for medical practices and institutions to quickly and securely manage their patients'...
PRAC adopts new strategy on measuring impact of pharmacovigilance activities
The Pharmacovigilance Risk Assessment Committee (PRAC), at its January meeting, adopted a 'Strategy on measuring the impact of pharmacovigilance activities'. Read more: Pharmabiz.com
Health Policy Brief: Transparency In Clinical Research
A new policy brief from Health Affairs and the Robert Wood Johnson Foundation (RWJF) examines past and present initiatives to improve the use of clinical research for patients, providers, and health systems. Read more: healthaffairs.org
Biopsy Requirements Impede Enrollment in Clinical Trials for Advanced NSCLC
A study analysis tackles the ethical debate surrounding the impact of the increasing requirement for research biopsies on the participation of patients with advanced non–small lung cancer (NSCLC) in clinical trials. Read more: targetedonc.com
Geron Announces Initiation Of Janssen Phase 2/3 Clinical Trial Of Imetelstat In Myelodysplastic Syndromes
Geron Corporation (Nasdaq:GERN) today announced the dosing of the first patient in a Phase 2/3 clinical trial to evaluate imetelstat in patients with myelodysplastic syndromes (MDS). Read more: clinicalearder.com